Latest Breaking News On - Spyre therapeutics - Page 3 : comparemela.com

Spyre Therapeutics (NASDAQ:SYRE) Releases Quarterly Earnings Results, Misses Estimates By $0.30 EPS

Spyre Therapeutics (NASDAQ:SYRE) Releases Quarterly Earnings Results, Misses Estimates By $0.30 EPS
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird
Stifel-nicolaus
Wells-fargo-company
Spyre-therapeutics-inc
Spyre-therapeutics-company-profile
Spyre-therapeutics
Get-free-report
Spyre-therapeutics-daily

Spyre Therapeutics (NASDAQ:SYRE) Issues Quarterly Earnings Results, Misses Expectations By $0.30 EPS

Spyre Therapeutics (NASDAQ:SYRE) Issues Quarterly Earnings Results, Misses Expectations By $0.30 EPS
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird
Stifel-nicolaus
Spyre-therapeutics-inc
Wells-fargo-company
Spyre-therapeutics
Get-free-report
Therapeutics-trading-down
Spyre-therapeutics-daily

BTIG Research Raises Spyre Therapeutics (NASDAQ:SYRE) Price Target to $40.00

BTIG Research Raises Spyre Therapeutics (NASDAQ:SYRE) Price Target to $40.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird
Stifel-nicolaus
Spyre-therapeutics-inc
Wells-fargo-company
Spyre-therapeutics
Free-report
Get-free-report
Spyre-therapeutics-daily

SYRE Stock Earnings: Spyre Therapeutics Misses EPS for Q1 2024

SYRE Stock Earnings: Spyre Therapeutics Misses EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Spyre-therapeutics
Place-earnings

Head to Head Comparison: Spyre Therapeutics (NASDAQ:SYRE) & NexImmune (NASDAQ:NEXI)

NexImmune (NASDAQ:NEXI – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 9.9% of NexImmune shares […]

Gaithersburg
Maryland
United-states
Waltham
Massachusetts
Neximmune-inc
Aeglea-biotherapeutics-inc
Spyre-therapeutics-inc
Get-free-report
Spyre-therapeutics
Spyre-therapeutic